Protocol of a randomised controlled trial assessing the impact of physical activity on bone health in children with inflammatory bowel disease.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
18 05 2020
Historique:
entrez: 21 5 2020
pubmed: 21 5 2020
medline: 15 5 2021
Statut: epublish

Résumé

Low bone mineral density (BMD) is a frequent issue in children and adolescents with inflammatory bowel disease (IBD). Several studies in healthy populations have reported a positive impact of physical activity (PA) on bone health. Recently, an observational study in paediatric patients with IBD showed a significant positive relationship between daily PA and BMD. However, intervention studies investigating a causal relationship between PA and BMD are warranted to confirm these results. The aim of this randomised controlled trial will be to investigate the effect of a PA programme on BMD in paediatric patients with IBD. This trial is a multicentre (four centres), randomised, controlled, blinded end-point study. Eighty children with IBD will be randomly assigned in a 1:1 ratio to receive a programme with adapted physical exercises (intervention group) or usual PA (control group) during a 9-month period. The primary outcome is the change from baseline at 9 months (the end of the study) in whole-body BMD assessed by dual-energy X-ray absorptiometry. Secondary efficacy outcomes include the changes from baseline at 9 months in: BMD assessed in the lumbar spine and trochanter; daily PA (time spent in moderate-to-vigorous PA); body composition (fat mass and fat-free mass); fatigue resistance; quality of life and activity of IBD. The study was approved by the Research Ethics Committee in France (Comité de Protection des Personnes, Sud-Ouest and Outre-Mer III, Bordeaux, France, No 2018/27). All procedures will be performed according to the ethical standards of the Helsinki Declaration of 1975, as revised in 2008, and the European Union's Guidelines for Good Clinical Practice. Written informed consent will be obtained from the parents or legal guardian and from the children. Research findings will be disseminated in peer-reviewed journals and scientific meetings. NCT03774329.

Identifiants

pubmed: 32430452
pii: bmjopen-2019-036400
doi: 10.1136/bmjopen-2019-036400
pmc: PMC7239538
doi:

Banques de données

ClinicalTrials.gov
['NCT03774329']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e036400

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Pediatr Gastroenterol Nutr. 2006 Jul;43(1):42-51
pubmed: 16819376
United European Gastroenterol J. 2016 Oct;4(5):669-676
pubmed: 27733909
Eur J Appl Physiol. 2016 Jul;116(7):1297-304
pubmed: 27146169
Med Sci Sports Exerc. 2016 Feb;48(2):245-53
pubmed: 26375253
J Pediatr Gastroenterol Nutr. 2004 Mar;38(3):276-80
pubmed: 15076625
Gastroenterol Clin Biol. 2010 Oct;34(10):554-61
pubmed: 20739132
J Pediatr Gastroenterol Nutr. 1991 May;12(4):439-47
pubmed: 1678008
Stat Med. 2009 Sep 10;28(20):2509-30
pubmed: 19610129
Clin Nutr. 2019 Jul 26;:
pubmed: 31427183
Sports Med. 2006;36(12):1019-30
pubmed: 17123326
Am J Gastroenterol. 2018 Feb;113(2):265-272
pubmed: 28809388
Int J Sports Med. 2012 Aug;33(8):671-9
pubmed: 22562735
BMC Med Res Methodol. 2005 Nov 03;5:35
pubmed: 16269081
BMC Med Res Methodol. 2019 Apr 2;19(1):72
pubmed: 30940079
Inflamm Bowel Dis. 2002 Mar;8(2):87-92
pubmed: 11854605
Gastroenterology. 1998 Jul;115(1):36-41
pubmed: 9649456
Bone. 2007 Jan;40(1):14-27
pubmed: 16956802
Bone. 2009 Nov;45(5):925-30
pubmed: 19664736
J Crohns Colitis. 2012 Jul;6(6):665-73
pubmed: 22398103
BMC Gastroenterol. 2017 Dec 12;17(1):160
pubmed: 29233119
Calcif Tissue Int. 2001 Apr;68(4):235-9
pubmed: 11353951
J Pediatr Hematol Oncol. 2007 Jul;29(7):471-9
pubmed: 17609625
J Pediatr Gastroenterol Nutr. 2012 Nov;55(5):511-8
pubmed: 22688562
PLoS One. 2013 Apr 23;8(4):e61691
pubmed: 23626718
J Bone Miner Res. 2001 Jan;16(1):166-74
pubmed: 11149481
Sports Med. 2006;36(9):723-32
pubmed: 16937949
J Pediatr Gastroenterol Nutr. 2002 Oct;35(4):557-63
pubmed: 12394384
Pediatr Exerc Sci. 2015 May;27(2):219-25
pubmed: 25389217
Clin J Sport Med. 2017 Jan;27(1):69-77
pubmed: 26825141
Curr Osteoporos Rep. 2003 Sep;1(2):78-85
pubmed: 16036069
Biometrics. 1982 Sep;38(3):715-24
pubmed: 7171697
Gastroenterology. 2007 Aug;133(2):423-32
pubmed: 17681163
An Pediatr (Barc). 2014 Dec;81(6):343-51
pubmed: 24582519
Sports Med. 2016 Mar;46(3):365-79
pubmed: 26607734
Aliment Pharmacol Ther. 2005 May 1;21(9):1073-83
pubmed: 15854168
J Exp Biol. 2001 Oct;204(Pt 19):3389-99
pubmed: 11606612
Eur J Gastroenterol Hepatol. 2018 Apr;30(4):471-476
pubmed: 29438136
Bone. 1995 Jan;16(1):73-80
pubmed: 7742087
Pediatr Res. 2019 Aug;86(2):149-156
pubmed: 31029060
Med Sci Sports Exerc. 1995 Apr;27(4):520-9
pubmed: 7791582
Arch Dis Child. 1976 Mar;51(3):170-9
pubmed: 952550
J Bone Miner Res. 2011 Aug;26(8):1729-39
pubmed: 21520276
Lancet. 2018 Dec 23;390(10114):2769-2778
pubmed: 29050646

Auteurs

Jérémy Vanhelst (J)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France, Lille, France jeremy.vanhelst@chru-lille.fr.

Stéphanie Coopman (S)

Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Lille University, Jeanne de Flandre Children's Hospital, Lille, France.

Julien Labreuche (J)

Univ. Lille, CHU Lille, ULR 2694 - METRICS: Evaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France, Lille, France.

Claire Dupont (C)

Department of Paediatrics, Caen University Hospital F 14000 Caen, France and Normandy University, Caen, France.

Valérie Bertrand (V)

Pediatric Unit, Le Havre Hospital, Le Havre, France.

Djamal Djeddi (D)

Department of Paediatrics, Amiens University Hospital and University of Amiens, Amiens, France.

Dominique Turck (D)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France, Lille, France.
Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Lille University, Jeanne de Flandre Children's Hospital, Lille, France.

Delphine Ley (D)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France, Lille, France.
Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Lille University, Jeanne de Flandre Children's Hospital, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH